非布司他片多少钱一盒呢？

(Alias: Febuxostat) inhibits the production of uric acid in the body and reduces the content of uric acid in the blood. Under normal circumstances, it can treat gout and hyperuricemia. How much does a box of febuxostat tablets cost?

Price of Febuxostat: It is understood that the price of Febuxostat on the domestic market is relatively expensive and is not suitable for patients to take it for a long time. What I need to tell you here is that the efficacy of Febuxostat produced by Zydus Pharmaceutical Factory in India is the same as that of the original drug, and the price is indeed much lower. The specification is 80mg*30 tablets/box. Its price is about 200$. Due to the floating exchange rate, the price is different. Please consult the medical companion for the specific price.

The methods generally used to treat gout are: promoting the metabolism of uric acid and inhibiting the conversion of uric acid, and taking appropriate measures to improve related symptoms.

Febuxostat is a newly developed XOR retardant in the world. It can selectively act on this antibiotic through a high degree of efficacy, reduce the production of blood uric acid in the body, lower cholesterol levels, and thus effectively treat ventilation symptoms.

Compared with allopurine, febuxostat has significant advantages:

(1) Allopurinol only has an inhibitory effect on the reduced form of XOR, while febuxostat has a significant inhibitory effect on both air-oxidized and reduced forms of XOR, so its cholesterol-lowering effect is more powerful and long-lasting;

(2) Because allopurinol is an analogue of pyridine, it is inevitably affected by other enzymatic reactions involving pyridine and pyridine metabolism. Therefore, during allopurinol treatment, repeated large-dose administration is required to maintain a high drug level. This may also result in serious or even fatal side effects caused by drug accumulation. It is a non-pyroxine type XOR retarder, so it has a stronger safety factor!

Recommended related hot articles: ttps:///newsDetail/74596.html